Special Issue "Novel Imaging Probes: From Design to Applications"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 5652
Molecular imaging has developed rapidly, becoming a vital tool for early clinical diagnosis, therapy monitoring, and risk stratification. Notably, achieving high-quality images heavily relies on a highly sensitive and selective imaging probe. The recent development of target-specific tracers with different imaging modalities, such as photon emission computerized tomography (SPECT), positron emission tomography (PET), and optical imaging, has experienced incredible growth. From random screening to rational design, we have seen scientists across the fields of biology, chemistry, pharmacy, and computer science develop various strategies to find probes for specific biomarkers of different diseases. Improving the pharmacokinetic characteristics of imaging probes for clinical applications is as well emphasized. On the other hand, advances in nanomaterials, radiochemistry, and new-generation fluorophores (ex. NIRF-II) have added great support to the in vivo applications of imaging probes. Furthermore, combining an imaging probe and a therapeutic drug to be a single theragnostic agent is likely a new trend that expands the application of imaging probes. In this Special Issue, “Novel Imaging Probes: From Design to Applications”, we aim to collect both original and review articles that focus on molecular imaging probe design, novel strategies of probe development, and preclinical and clinical translational studies of new imaging probes. Experts in these fields are encouraged to contribute their recent works to this Special Issue of Pharmaceuticals.
Dr. Kuo-Ting Chen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular imaging
- imaging probe development strategy
- imaging probe design
- applications of imaging probes
- optical imaging